These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1982016)

  • 1. [Human immunodeficiency virus type 2 infection: is it really present in our area?].
    Corzo JE; Calderón E; Rey C; Leal M
    Med Clin (Barc); 1990 Oct; 95(11):436-7. PubMed ID: 1982016
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory diagnosis of the first cases of HIV-2 infection in Canada.
    Neumann PW; O'Shaughnessy MV; Lepine D; D'Souza I; Major C; McLaughlin B
    CMAJ; 1989 Jan; 140(2):125-8. PubMed ID: 2562925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Human immunodeficiency virus type 2 infection in Western Africans living in Catalonia].
    Soriano V; Tor J; Muga R; Fernández JL; Ribera A; Balanzó X; Foz M
    Med Clin (Barc); 1989 Feb; 92(5):161-3. PubMed ID: 2657255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 2 in Spain.
    Soriano V; Tor J; Ribera A
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):568. PubMed ID: 2569973
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-2 in Spain.
    Soriano V; Tor J; Ribera A
    Transfusion; 1989 Oct; 29(8):749. PubMed ID: 2572079
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of transfusional infection caused by human immunodeficiency virus].
    Soriano V; González-Lahoz J
    Med Clin (Barc); 1991 Sep; 97(10):380-2. PubMed ID: 1683915
    [No Abstract]   [Full Text] [Related]  

  • 7. [Search for antibodies against human immunodeficiency virus type 2 (HIV-2) in a sample of parenteral drug addicts (IVDA)].
    Ortiz de Lejarazu R; Eiros JM; Perlado del Campo E; Palenzuela MS; Reguera JI; Rodríguez-Torres A
    Enferm Infecc Microbiol Clin; 1990 Jan; 8(1):48-51. PubMed ID: 2095905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of anti-HIV-2 antibodies in a population at risk attending the drug-dependence center of the Rho hospital].
    Albert F; Corazza M; Rotondi L; Segrè C
    Boll Ist Sieroter Milan; 1989; 68(2):122-6. PubMed ID: 2577476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of HIV-2 prevalence in France.
    Couroucé AM
    AIDS; 1988 Aug; 2(4):261-5. PubMed ID: 2902863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Notes on AIDS].
    Clin Ter; 1988 Mar; 124(6):489-92. PubMed ID: 2904848
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-2 in west Africa in 1966.
    Kawamura M; Yamazaki S; Ishikawa K; Kwofie TB; Tsujimoto H; Hayami M
    Lancet; 1989 Feb; 1(8634):385. PubMed ID: 2563537
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthetic peptide immunoassay for diagnosis of HIV 2 infection.
    Soriano V; Tor J; Ribera A; Martin J; Foz M
    Vox Sang; 1989; 57(3):222. PubMed ID: 2575825
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of the Abbott recombinant HIV-1/HIV-2 enzyme immunoassay for the detection of HIV antibodies.
    Gershy-Damet GM; Kodjo M; Benoit S
    AIDS; 1990 Jan; 4(1):87-8. PubMed ID: 2156529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Penetration of the infection caused by type 2 human immunodeficiency virus in Andalusian individuals at risk].
    Pineda JA; Calderón E; Rey C; Leal M
    Med Clin (Barc); 1989 Oct; 93(10):394-5. PubMed ID: 2575197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Type-2 human immunodeficiency virus: a study in the central region (communities of Madrid and Castilla La Mancha].
    Cour MJ; González Cuadrado S; Fernández ME; Ladrón de Guevara J
    Med Clin (Barc); 1990 Apr; 94(16):638. PubMed ID: 2381251
    [No Abstract]   [Full Text] [Related]  

  • 16. No evidence of HIV 2 infection in Sicily.
    Russo Alesi D; Vitale F; Lupo G; La Licata R; Zambito F; Romano N
    Microbiologica; 1989 Jul; 12(3):195-201. PubMed ID: 2674633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
    Cooke FJ; Geretti AM; Zuckerman M
    J Med Virol; 2005 Jun; 76(2):143-5. PubMed ID: 15834880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-2 in The Netherlands].
    van Doornum GJ; van den Akker R; Buitenwerf J; Kroes AC; Coutinho RA; Lelie PN
    Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2129-33. PubMed ID: 1682827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). The Spanish Group for the Study of HIV-2].
    Soriano V; Gutiérrez M; Tuset C; Martínez-Zapico R; Ortiz de Lejarazu R; Aguilera A; Codina G; González A; Ulloa F; Leal M
    Med Clin (Barc); 1993 Apr; 100(14):531-5. PubMed ID: 8469039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region].
    Antinori A; Tamburrini E; Ventura G; Nervo P; Ortona L
    Boll Ist Sieroter Milan; 1988; 67(5-6):345-50. PubMed ID: 2908738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.